Role of O6-methylguanine-DNA methyltransferase and effect of O6-benzylguanine on the anti-tumor activity of cis-diaminedichloroplatinum (II) in oral cancer cell lines

The DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT) modulates the effectiveness of alkylating agents. However, the relationship between MGMT and the sensitivities to other agents has not been explored. In the present study, the association between MGMT expression and the cellular sen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oral oncology 2005-11, Vol.41 (10), p.984-993
Hauptverfasser: MAKI, Yu, MURAKAMI, Jun, TANAKA, Noriaki, MATSUBARA, Nagahide, KISHI, Kanji, ASAUMI, Jun-Ichi, TSUJIGIWA, Hidetsugu, NAGATSUKA, Hitoshi, KOKEGUCHI, Susumu, FUKUI, Kazuhiro, KAWAI, Noriko, YANAGI, Yoshinobu, KURODA, Masahiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 993
container_issue 10
container_start_page 984
container_title Oral oncology
container_volume 41
creator MAKI, Yu
MURAKAMI, Jun
TANAKA, Noriaki
MATSUBARA, Nagahide
KISHI, Kanji
ASAUMI, Jun-Ichi
TSUJIGIWA, Hidetsugu
NAGATSUKA, Hitoshi
KOKEGUCHI, Susumu
FUKUI, Kazuhiro
KAWAI, Noriko
YANAGI, Yoshinobu
KURODA, Masahiro
description The DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT) modulates the effectiveness of alkylating agents. However, the relationship between MGMT and the sensitivities to other agents has not been explored. In the present study, the association between MGMT expression and the cellular sensitivity to the platinum agent, CDDP was examined in four human oral cancer cell lines. CDDP depleted MGMT protein and mRNA levels in all four cell lines. Two cell lines with low MGMT expression were sensitive to an alkylating agent, N-methyl-N'-nitro-N-nitrosoguanidine and CDDP, whereas two other cell lines with high MGMT expression were resistant to both agents. Furthermore, the addition of the MGMT inhibitor, O6-benzylguanine (O6-BG), invariably enhanced CDDP sensitivity. CDDP depleted MGMT expression, and CDDP sensitivity was enhanced by O6-BG. These results provide valuable information about the relationship between MGMT expression and CDDP sensitivity in oral cancer chemotherapy.
doi_str_mv 10.1016/j.oraloncology.2005.05.011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68692276</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68692276</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2441-114a6396b3a336138f1d29353df1bd9bf073bb1230e5fb4b8b11dd2c3e2ed9023</originalsourceid><addsrcrecordid>eNpNkV2L1DAUhoso7of-BQmCohcdc5I2bfduWVcdWFwQvQ753MmQJmOSCuMP8nfaMsUVDiQcnjfJyVNVrwFvAAP7sN_EJHwMKvr4cNwQjNvNUgBPqnPou6HG7UCfznvK-rqnXXtWXeS8xzMILX5enQHDDaV9e179-Ra9QdGie1aPpuyO_mESwQVTf_x6jU6dkkTI1iSRDRJBI2OtUWUNSRN-_wuhGFDZLVRxdZnGmJBQxf1y5bjgyuVaOzHOpHZq52OKBy-KC9OI3m2375ELaBkNKRGUSUgZ75Gf6fyiemaFz-blul5WPz7dfr_5Ut_df97eXN_VijQN1ACNYHRgkgpKGdDegiYDbam2IPUgLe6olEAoNq2VjewlgNZEUUOMHjChl9Xb07mHFH9OJhc-urw8QwQTp8xZzwZCOjaDVydQpZhzMpYfkhtFOnLAfLHE9_x_S3yxxJcCmMOv1lsmORr9GF21zMCbFRBZCW9nAfPfPXIdDM3QNvQvE1OiVQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68692276</pqid></control><display><type>article</type><title>Role of O6-methylguanine-DNA methyltransferase and effect of O6-benzylguanine on the anti-tumor activity of cis-diaminedichloroplatinum (II) in oral cancer cell lines</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>MAKI, Yu ; MURAKAMI, Jun ; TANAKA, Noriaki ; MATSUBARA, Nagahide ; KISHI, Kanji ; ASAUMI, Jun-Ichi ; TSUJIGIWA, Hidetsugu ; NAGATSUKA, Hitoshi ; KOKEGUCHI, Susumu ; FUKUI, Kazuhiro ; KAWAI, Noriko ; YANAGI, Yoshinobu ; KURODA, Masahiro</creator><creatorcontrib>MAKI, Yu ; MURAKAMI, Jun ; TANAKA, Noriaki ; MATSUBARA, Nagahide ; KISHI, Kanji ; ASAUMI, Jun-Ichi ; TSUJIGIWA, Hidetsugu ; NAGATSUKA, Hitoshi ; KOKEGUCHI, Susumu ; FUKUI, Kazuhiro ; KAWAI, Noriko ; YANAGI, Yoshinobu ; KURODA, Masahiro</creatorcontrib><description>The DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT) modulates the effectiveness of alkylating agents. However, the relationship between MGMT and the sensitivities to other agents has not been explored. In the present study, the association between MGMT expression and the cellular sensitivity to the platinum agent, CDDP was examined in four human oral cancer cell lines. CDDP depleted MGMT protein and mRNA levels in all four cell lines. Two cell lines with low MGMT expression were sensitive to an alkylating agent, N-methyl-N'-nitro-N-nitrosoguanidine and CDDP, whereas two other cell lines with high MGMT expression were resistant to both agents. Furthermore, the addition of the MGMT inhibitor, O6-benzylguanine (O6-BG), invariably enhanced CDDP sensitivity. CDDP depleted MGMT expression, and CDDP sensitivity was enhanced by O6-BG. These results provide valuable information about the relationship between MGMT expression and CDDP sensitivity in oral cancer chemotherapy.</description><identifier>ISSN: 1368-8375</identifier><identifier>EISSN: 1879-0593</identifier><identifier>DOI: 10.1016/j.oraloncology.2005.05.011</identifier><identifier>PMID: 16043385</identifier><language>eng</language><publisher>Oxford: Elsevier</publisher><subject>Antineoplastic Agents - therapeutic use ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Biological and medical sciences ; Cell Line, Tumor - drug effects ; Cisplatin - administration &amp; dosage ; Cisplatin - antagonists &amp; inhibitors ; DNA Repair ; Drug Resistance, Neoplasm ; Guanine - analogs &amp; derivatives ; Guanine - metabolism ; Humans ; Medical sciences ; Methylnitronitrosoguanidine - therapeutic use ; Mouth Neoplasms - drug therapy ; Mouth Neoplasms - enzymology ; O-Methylguanine-DNA Methyltransferase - drug effects ; O-Methylguanine-DNA Methyltransferase - metabolism ; Otorhinolaryngology. Stomatology ; Taxoids - administration &amp; dosage ; Tumors ; Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</subject><ispartof>Oral oncology, 2005-11, Vol.41 (10), p.984-993</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2441-114a6396b3a336138f1d29353df1bd9bf073bb1230e5fb4b8b11dd2c3e2ed9023</citedby><cites>FETCH-LOGICAL-c2441-114a6396b3a336138f1d29353df1bd9bf073bb1230e5fb4b8b11dd2c3e2ed9023</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17194954$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16043385$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MAKI, Yu</creatorcontrib><creatorcontrib>MURAKAMI, Jun</creatorcontrib><creatorcontrib>TANAKA, Noriaki</creatorcontrib><creatorcontrib>MATSUBARA, Nagahide</creatorcontrib><creatorcontrib>KISHI, Kanji</creatorcontrib><creatorcontrib>ASAUMI, Jun-Ichi</creatorcontrib><creatorcontrib>TSUJIGIWA, Hidetsugu</creatorcontrib><creatorcontrib>NAGATSUKA, Hitoshi</creatorcontrib><creatorcontrib>KOKEGUCHI, Susumu</creatorcontrib><creatorcontrib>FUKUI, Kazuhiro</creatorcontrib><creatorcontrib>KAWAI, Noriko</creatorcontrib><creatorcontrib>YANAGI, Yoshinobu</creatorcontrib><creatorcontrib>KURODA, Masahiro</creatorcontrib><title>Role of O6-methylguanine-DNA methyltransferase and effect of O6-benzylguanine on the anti-tumor activity of cis-diaminedichloroplatinum (II) in oral cancer cell lines</title><title>Oral oncology</title><addtitle>Oral Oncol</addtitle><description>The DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT) modulates the effectiveness of alkylating agents. However, the relationship between MGMT and the sensitivities to other agents has not been explored. In the present study, the association between MGMT expression and the cellular sensitivity to the platinum agent, CDDP was examined in four human oral cancer cell lines. CDDP depleted MGMT protein and mRNA levels in all four cell lines. Two cell lines with low MGMT expression were sensitive to an alkylating agent, N-methyl-N'-nitro-N-nitrosoguanidine and CDDP, whereas two other cell lines with high MGMT expression were resistant to both agents. Furthermore, the addition of the MGMT inhibitor, O6-benzylguanine (O6-BG), invariably enhanced CDDP sensitivity. CDDP depleted MGMT expression, and CDDP sensitivity was enhanced by O6-BG. These results provide valuable information about the relationship between MGMT expression and CDDP sensitivity in oral cancer chemotherapy.</description><subject>Antineoplastic Agents - therapeutic use</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Cell Line, Tumor - drug effects</subject><subject>Cisplatin - administration &amp; dosage</subject><subject>Cisplatin - antagonists &amp; inhibitors</subject><subject>DNA Repair</subject><subject>Drug Resistance, Neoplasm</subject><subject>Guanine - analogs &amp; derivatives</subject><subject>Guanine - metabolism</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Methylnitronitrosoguanidine - therapeutic use</subject><subject>Mouth Neoplasms - drug therapy</subject><subject>Mouth Neoplasms - enzymology</subject><subject>O-Methylguanine-DNA Methyltransferase - drug effects</subject><subject>O-Methylguanine-DNA Methyltransferase - metabolism</subject><subject>Otorhinolaryngology. Stomatology</subject><subject>Taxoids - administration &amp; dosage</subject><subject>Tumors</subject><subject>Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</subject><issn>1368-8375</issn><issn>1879-0593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkV2L1DAUhoso7of-BQmCohcdc5I2bfduWVcdWFwQvQ753MmQJmOSCuMP8nfaMsUVDiQcnjfJyVNVrwFvAAP7sN_EJHwMKvr4cNwQjNvNUgBPqnPou6HG7UCfznvK-rqnXXtWXeS8xzMILX5enQHDDaV9e179-Ra9QdGie1aPpuyO_mESwQVTf_x6jU6dkkTI1iSRDRJBI2OtUWUNSRN-_wuhGFDZLVRxdZnGmJBQxf1y5bjgyuVaOzHOpHZq52OKBy-KC9OI3m2375ELaBkNKRGUSUgZ75Gf6fyiemaFz-blul5WPz7dfr_5Ut_df97eXN_VijQN1ACNYHRgkgpKGdDegiYDbam2IPUgLe6olEAoNq2VjewlgNZEUUOMHjChl9Xb07mHFH9OJhc-urw8QwQTp8xZzwZCOjaDVydQpZhzMpYfkhtFOnLAfLHE9_x_S3yxxJcCmMOv1lsmORr9GF21zMCbFRBZCW9nAfPfPXIdDM3QNvQvE1OiVQ</recordid><startdate>200511</startdate><enddate>200511</enddate><creator>MAKI, Yu</creator><creator>MURAKAMI, Jun</creator><creator>TANAKA, Noriaki</creator><creator>MATSUBARA, Nagahide</creator><creator>KISHI, Kanji</creator><creator>ASAUMI, Jun-Ichi</creator><creator>TSUJIGIWA, Hidetsugu</creator><creator>NAGATSUKA, Hitoshi</creator><creator>KOKEGUCHI, Susumu</creator><creator>FUKUI, Kazuhiro</creator><creator>KAWAI, Noriko</creator><creator>YANAGI, Yoshinobu</creator><creator>KURODA, Masahiro</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200511</creationdate><title>Role of O6-methylguanine-DNA methyltransferase and effect of O6-benzylguanine on the anti-tumor activity of cis-diaminedichloroplatinum (II) in oral cancer cell lines</title><author>MAKI, Yu ; MURAKAMI, Jun ; TANAKA, Noriaki ; MATSUBARA, Nagahide ; KISHI, Kanji ; ASAUMI, Jun-Ichi ; TSUJIGIWA, Hidetsugu ; NAGATSUKA, Hitoshi ; KOKEGUCHI, Susumu ; FUKUI, Kazuhiro ; KAWAI, Noriko ; YANAGI, Yoshinobu ; KURODA, Masahiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2441-114a6396b3a336138f1d29353df1bd9bf073bb1230e5fb4b8b11dd2c3e2ed9023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Antineoplastic Agents - therapeutic use</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Cell Line, Tumor - drug effects</topic><topic>Cisplatin - administration &amp; dosage</topic><topic>Cisplatin - antagonists &amp; inhibitors</topic><topic>DNA Repair</topic><topic>Drug Resistance, Neoplasm</topic><topic>Guanine - analogs &amp; derivatives</topic><topic>Guanine - metabolism</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Methylnitronitrosoguanidine - therapeutic use</topic><topic>Mouth Neoplasms - drug therapy</topic><topic>Mouth Neoplasms - enzymology</topic><topic>O-Methylguanine-DNA Methyltransferase - drug effects</topic><topic>O-Methylguanine-DNA Methyltransferase - metabolism</topic><topic>Otorhinolaryngology. Stomatology</topic><topic>Taxoids - administration &amp; dosage</topic><topic>Tumors</topic><topic>Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MAKI, Yu</creatorcontrib><creatorcontrib>MURAKAMI, Jun</creatorcontrib><creatorcontrib>TANAKA, Noriaki</creatorcontrib><creatorcontrib>MATSUBARA, Nagahide</creatorcontrib><creatorcontrib>KISHI, Kanji</creatorcontrib><creatorcontrib>ASAUMI, Jun-Ichi</creatorcontrib><creatorcontrib>TSUJIGIWA, Hidetsugu</creatorcontrib><creatorcontrib>NAGATSUKA, Hitoshi</creatorcontrib><creatorcontrib>KOKEGUCHI, Susumu</creatorcontrib><creatorcontrib>FUKUI, Kazuhiro</creatorcontrib><creatorcontrib>KAWAI, Noriko</creatorcontrib><creatorcontrib>YANAGI, Yoshinobu</creatorcontrib><creatorcontrib>KURODA, Masahiro</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Oral oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MAKI, Yu</au><au>MURAKAMI, Jun</au><au>TANAKA, Noriaki</au><au>MATSUBARA, Nagahide</au><au>KISHI, Kanji</au><au>ASAUMI, Jun-Ichi</au><au>TSUJIGIWA, Hidetsugu</au><au>NAGATSUKA, Hitoshi</au><au>KOKEGUCHI, Susumu</au><au>FUKUI, Kazuhiro</au><au>KAWAI, Noriko</au><au>YANAGI, Yoshinobu</au><au>KURODA, Masahiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of O6-methylguanine-DNA methyltransferase and effect of O6-benzylguanine on the anti-tumor activity of cis-diaminedichloroplatinum (II) in oral cancer cell lines</atitle><jtitle>Oral oncology</jtitle><addtitle>Oral Oncol</addtitle><date>2005-11</date><risdate>2005</risdate><volume>41</volume><issue>10</issue><spage>984</spage><epage>993</epage><pages>984-993</pages><issn>1368-8375</issn><eissn>1879-0593</eissn><abstract>The DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT) modulates the effectiveness of alkylating agents. However, the relationship between MGMT and the sensitivities to other agents has not been explored. In the present study, the association between MGMT expression and the cellular sensitivity to the platinum agent, CDDP was examined in four human oral cancer cell lines. CDDP depleted MGMT protein and mRNA levels in all four cell lines. Two cell lines with low MGMT expression were sensitive to an alkylating agent, N-methyl-N'-nitro-N-nitrosoguanidine and CDDP, whereas two other cell lines with high MGMT expression were resistant to both agents. Furthermore, the addition of the MGMT inhibitor, O6-benzylguanine (O6-BG), invariably enhanced CDDP sensitivity. CDDP depleted MGMT expression, and CDDP sensitivity was enhanced by O6-BG. These results provide valuable information about the relationship between MGMT expression and CDDP sensitivity in oral cancer chemotherapy.</abstract><cop>Oxford</cop><pub>Elsevier</pub><pmid>16043385</pmid><doi>10.1016/j.oraloncology.2005.05.011</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1368-8375
ispartof Oral oncology, 2005-11, Vol.41 (10), p.984-993
issn 1368-8375
1879-0593
language eng
recordid cdi_proquest_miscellaneous_68692276
source MEDLINE; Elsevier ScienceDirect Journals
subjects Antineoplastic Agents - therapeutic use
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Biological and medical sciences
Cell Line, Tumor - drug effects
Cisplatin - administration & dosage
Cisplatin - antagonists & inhibitors
DNA Repair
Drug Resistance, Neoplasm
Guanine - analogs & derivatives
Guanine - metabolism
Humans
Medical sciences
Methylnitronitrosoguanidine - therapeutic use
Mouth Neoplasms - drug therapy
Mouth Neoplasms - enzymology
O-Methylguanine-DNA Methyltransferase - drug effects
O-Methylguanine-DNA Methyltransferase - metabolism
Otorhinolaryngology. Stomatology
Taxoids - administration & dosage
Tumors
Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology
title Role of O6-methylguanine-DNA methyltransferase and effect of O6-benzylguanine on the anti-tumor activity of cis-diaminedichloroplatinum (II) in oral cancer cell lines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T06%3A00%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20O6-methylguanine-DNA%20methyltransferase%20and%20effect%20of%20O6-benzylguanine%20on%20the%20anti-tumor%20activity%20of%20cis-diaminedichloroplatinum%20(II)%20in%20oral%20cancer%20cell%20lines&rft.jtitle=Oral%20oncology&rft.au=MAKI,%20Yu&rft.date=2005-11&rft.volume=41&rft.issue=10&rft.spage=984&rft.epage=993&rft.pages=984-993&rft.issn=1368-8375&rft.eissn=1879-0593&rft_id=info:doi/10.1016/j.oraloncology.2005.05.011&rft_dat=%3Cproquest_cross%3E68692276%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68692276&rft_id=info:pmid/16043385&rfr_iscdi=true